Glucocorticoid Mediated Signaling in Breast Cancer
Glucocorticoid Mediated Signaling in Breast Cancer
批准号:
6787625
负责人:
Suzanne Daniela Conzen
金额:
$21.73万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-08-01 至 2006-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The identification of anti-apoptotic
signaling mechanisms has provided an experimental framework for understanding
how pre-malignant and malignant cells can escape environmental signals that
would normally initiate programmed cell death in human mammary epithelial cells
(MECs). we have recently defined a novel glucocorticoid receptor (GR)-mediated
anti-apoptotic signaling pathway that is induced by physiological
concentrations of glucocorticoid and inhibited by GR-specific antagonists
(anti-glucocorticoids). Although it is well established that glucocorticoids
activate the glucocorticoid receptor (GR) and in turn regulate transcription,
the precise mechanism of glucocorticoid-mediated survival signaling in
epithelial cells is not known. Recently, our laboratory has found that ectopic
expression of a GR-transactivated gene, serum and glucocorticoid-inducible
kinase (SGK), inhibits apoptosis in MECs. This finding suggests that SGK, a
putative serinethreonine kinase, is a bona fide transcriptional target of GR
activation that orchestrates UR-initiated survival signaling. In addition to
transcriptional activation by the GR and post-translational phosphorylation by
upstream kinases, we have discovered that SGK protein expression is regulated
via proteasome-mediated degradation, revealing yet another level of regulation
of SGK activity. The overall goal of this grant is to understand the extent and
manner through which OR-induced SGK expression contributes to MEC survival. To
this end, we will first determine the specific steps in the apoptotic cascade
that are inhibited by glucocorticoids and then determine whether or not SGK
activity can substitute for GR activation. Second, we will examine the role of
OR activation and PI3-K/PDK-l.2 signaling in activating SOK's kinase activity
and in subsequently inhibiting apoptosis. Finally, we will characterize the
proteasome-mediated mechanism underlying wild type SGK's rapid proteolysis.
Together these studies are likely to lead to a detailed understanding of the
mechanisms regulating the GR-SGK anti-apoptotic pathway.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Estrogen and glucocorticoid receptor crosstalk in ER+ breast
-
批准号:10390341
-
项目类别:
-
资助金额:$23.99万
-
财政年份:2019
-
负责人:Suzanne Daniela Conzen
-
依托单位:
Estrogen and glucocorticoid receptor crosstalk in ER+ breast
-
批准号:10557108
-
项目类别:
-
资助金额:$36.76万
-
财政年份:2019
-
负责人:Suzanne Daniela Conzen
-
依托单位:
Estrogen and glucocorticoid receptor crosstalk in ER+ breast
-
批准号:10215442
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Suzanne Daniela Conzen
-
依托单位:
Identifying mechanisms linking stress biology to human breast cancer
-
批准号:8847659
-
项目类别:
-
资助金额:$31.92万
-
财政年份:2011
-
负责人:Suzanne Daniela Conzen
-
依托单位:
Identifying mechanisms linking stress biology to human breast cancer
-
批准号:8455711
-
项目类别:
-
资助金额:$30.01万
-
财政年份:2011
-
负责人:Suzanne Daniela Conzen
-
依托单位:
Identifying mechanisms linking stress biology to human breast cancer
-
批准号:8109156
-
项目类别:
-
资助金额:$31.92万
-
财政年份:2011
-
负责人:Suzanne Daniela Conzen
-
依托单位:
Identifying mechanisms linking stress biology to human breast cancer
-
批准号:8669922
-
项目类别:
-
资助金额:$30.97万
-
财政年份:2011
-
负责人:Suzanne Daniela Conzen
-
依托单位:
The role of SGK1 in triple-negative breast cancer resistance to treatment
-
批准号:8145547
-
项目类别:
-
资助金额:$21.56万
-
财政年份:2010
-
负责人:Suzanne Daniela Conzen
-
依托单位:
The role of SGK1 in triple-negative breast cancer resistance to treatment
-
批准号:7880513
-
项目类别:
-
资助金额:$18.53万
-
财政年份:2010
-
负责人:Suzanne Daniela Conzen
-
依托单位:
Glucocorticoid receptor-mediated survival signaling in breast cancer
-
批准号:7848431
-
项目类别:
-
资助金额:$1.91万
-
财政年份:2009
-
负责人:Suzanne Daniela Conzen
-
依托单位:
Social Isolation and Response to Mammary Cancer Therapy
-
批准号:7515215
-
项目类别:
-
资助金额:$24.19万
-
财政年份:2007
-
负责人:Suzanne Daniela Conzen
-
依托单位:
Glucocorticoid receptor-mediated survival signaling in breast cancer
-
批准号:8297902
-
项目类别:
-
资助金额:$23.36万
-
财政年份:2002
-
负责人:Suzanne Daniela Conzen
-
依托单位:
Glucocorticoid receptor-mediated survival signaling in breast cancer
-
批准号:8526401
-
项目类别:
-
资助金额:$21.96万
-
财政年份:2002
-
负责人:Suzanne Daniela Conzen
-
依托单位:
Glucocorticoid receptor-mediated survival signaling in breast cancer
-
批准号:7798228
-
项目类别:
-
资助金额:$22.69万
-
财政年份:2002
-
负责人:Suzanne Daniela Conzen
-
依托单位:
Glucocorticoid Mediated Signaling in Breast Cancer
-
批准号:6437108
-
项目类别:
-
资助金额:$21.73万
-
财政年份:2002
-
负责人:Suzanne Daniela Conzen
-
依托单位:
Glucocorticoid receptor-mediated survival signaling in breast cancer
-
批准号:7405456
-
项目类别:
-
资助金额:$22.69万
-
财政年份:2002
-
负责人:Suzanne Daniela Conzen
-
依托单位:
Glucocorticoid Mediated Signaling in Breast Cancer
-
批准号:6608907
-
项目类别:
-
资助金额:$21.73万
-
财政年份:2002
-
负责人:Suzanne Daniela Conzen
-
依托单位:
Glucocorticoid receptor-mediated survival signaling in breast cancer
-
批准号:7586264
-
项目类别:
-
资助金额:$22.69万
-
财政年份:2002
-
负责人:Suzanne Daniela Conzen
-
依托单位:
Glucocorticoid receptor-mediated survival signaling in breast cancer
-
批准号:8628056
-
项目类别:
-
资助金额:$22.66万
-
财政年份:2002
-
负责人:Suzanne Daniela Conzen
-
依托单位:
Glucocorticoid receptor-mediated survival signaling in breast cancer
-
批准号:8825333
-
项目类别:
-
资助金额:$23.36万
-
财政年份:2002
-
负责人:Suzanne Daniela Conzen
-
依托单位:
海外基金